Stages of Lymphoma Cancer
Stage I Lymphoma
- SCCA patients are represented by the green line. Their five-year survival rate was 82 percent from the time they were first diagnosed by SCCA. Note that only patients who received all of their care from SCCA are included.
- Patients from the other types of treatment centers—Community Cancer Centers, Comprehensive Community Cancer Centers, and Academic/Research Hospitals—are represented by the yellow line. Their five-year survival rate was 71 percent.
Stage II Lymphoma
- SCCA patients are represented by the green line. Their five-year survival rate was 88 percent from the time they were first diagnosed by SCCA. Note that only patients who received all of their care from SCCA are included.
- Patients from the other types of treatment centers—Community Cancer Centers, Comprehensive Community Cancer Centers, and Academic/Research Hospitals—are represented by the yellow line. Their five-year survival rate was 65 percent.
Stage III Lymphoma
- SCCA patients are represented by the green line. Their five-year survival rate was 63 percent from the time they were first diagnosed by SCCA. Note that only patients who received all of their care from SCCA are included.
- Patients from the other types of treatment centers—Community Cancer Centers, Comprehensive Community Cancer Centers, and Academic/Research Hospitals—are represented by the yellow line. Their five-year survival rate was 58 percent.
Stage IV Lymphoma
- SCCA patients are represented by the green line. Their five-year survival rate was 72 percent from the time they were first diagnosed by SCCA. Note that only patients who received all of their care from SCCA are included.
- Patients from the other types of treatment centers—Community Cancer Centers, Comprehensive Community Cancer Centers, and Academic/Research Hospitals—are represented by the yellow line. Their combined five-year survival rate was 49 percent.
Prevention of Lymphoma Cancer
Full Range of Lymphoma Treatments
For non-Hodgkin’s lymphoma, the most common treatments are chemotherapy, radiation therapy, and targeted therapy with small-molecule drugs or antibodies (man-made versions of immune system proteins). Many people are cured with one or more of these treatments. Because lymphoma usually has spread by the time it is detected, doctors typically use surgery only for a biopsy to establish a diagnosis, not as part of treatment.
Treatment in Clinical Studies
Depending on your situation, your doctor may suggest other treatments, including options you can access by taking part in one of the many lymphoma clinical studies being conducted through Seattle Cancer Care Alliance (SCCA) and its founding organizations, Fred Hutchinson Cancer Research Center and UW Medicine. SCCA doctors are actively investigating new approaches to T-cell lymphomas, which are particularly challenging to treat with current therapies.
Bone Marrow Transplant
People whose disease is not cured with initial treatment or who get recurrent lymphoma may have a bone marrow transplant in combination with other therapies. Doctors at the Fred Hutchinson Transplant Program at SCCA pioneered bone marrow transplantation 40 years ago and have performed more transplants than any institution in the world
Comments
Post a Comment